Dynavax reports record HEPLISAV-B revenue, 26% growth in 2024, and strong 2025 guidance. Insights on shingles vaccine progress & market expansion.

Worldwide, hepatitis B is thought to be the second deadliest infection; about 5% of the global population are infection and ...

Hong Kong health authorities have apologised for mistakenly giving pneumococcal vaccines to two children at a health centre ...

The hepatitis B vaccine is one of the very first vaccines your baby will get before she leaves the hospital. This vaccine protects her from a dangerous (but preventable!) liver infection and is given ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

Deep Track, a Greenwich, Ct., investment management company that holds 13.5% of Dynavax's stock, pointed its finger at ...

The Department of Health is investigating and following up on an incident in which the pneumococcal vaccine was mistakenly ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...